Cholangiocarcinoma Market Growth Accelerated by Advancing Treatment Options

 


Cholangiocarcinoma, also known as bile duct cancer, is a rare type of cancer that forms in the bile ducts. The ducts carry bile from the liver to the small intestine. Symptoms of this cancer often do not show up until the later stages and include jaundice, itching, weight loss and abdominal pain. If detected early, cholangiocarcinoma can sometimes be treated successfully through surgery to remove the tumor. The development of new treatment approaches like radiofrequency ablation, photodynamic therapy and targeted drug therapies have proven beneficial for improving survival rates.


The global Cholangiocarcinoma Market is estimated to be valued at US$ 7,275.7 Mn in 2023 and is expected to exhibit a CAGR of 7.6% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market key trends:
Advancing treatment options for cholangiocarcinoma is one of the key trends driving market growth. Researchers are developing novel therapies targeting specific gene mutations and pathways involved in the development and progression of this cancer. For example, drugs that block the Epidermal Growth Factor Receptor (EGFR) pathway have shown promising results in clinical trials for improving outcomes. Combination therapies using EGFR inhibitors with chemotherapy are being evaluated. Immunotherapy is another emerging treatment approach gaining attention. Checkpoint inhibitors that help boost the immune system's ability to fight cancer cells show potential. Their combination with other therapies may further enhance treatment effectiveness against cholangiocarcinoma. These innovative treatment strategies offer new hope to patients.

Segment Analysis
The global cholangiocarcinoma market is dominated by the intrahepatic sub segment. This is because intrahepatic cancer refers to the cancer which arises from the small branches of bile ducts inside the liver. As intrahepatic cancer arises in liver and spreads, it holds more than 50% share in overall cases of cholangiocarcinoma across the world.

Key Takeaways
The global cholangiocarcinoma market is expected to witness high growth. Factors such as increasing incidences of chronic liver diseases, rising geriatric population and growing healthcare expenditure will contribute to the growth of this market.

Regional analysis: The Asia Pacific region is expected to witness fastest growth in cholangiocarcinoma market during the forecast period. This is attributed to rising healthcare expenditure and ever increasing incidences of hepatobiliary diseases in developing countries such as India and China. North America is currently dominating the market however Asia Pacific is likely to take the leading position during the forecast period.

Key players operating in the cholangiocarcinoma market are Johnson & Johnson Services, Inc., Cooper Companies Inc., Lifecell Corporation (Allergan Plc), W. L. Gore & Associates, Inc., Maquet Holding B.V. & Co. KG, Becton, Dickinson and Company, Medtronic Plc, Cook Medical Inc., Baxter International Inc., and B. Braun Melsungen AG.

Comments

Post a Comment

Popular posts from this blog

Neuroendocrine Cancer is the fastest growing segment fueling the growth of Pituitary Cancer Market

Image
The pituitary cancer market comprises of medical treatment options for patients diagnosed with pituitary cancer. Pituitary cancers are rare tumors that start in the pituitary gland which is a pea-sized gland located at the base of the brain.  The global Pituitary Cancer Market is estimated to be valued at US$ 380.7 Mn in 2023 and is expected to exhibit a CAGR of 9.6% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.    Market key trends: One of the key trends fueling the growth of the pituitary cancer market is rising preference of targeted drug therapy over conventional chemotherapy. Targeted drug therapies mainly include somatostatin analogs and dopamine agonists which directly act on cancer cells and have less side effects compared to chemotherapy. These targeted drugs are effective in controlling symptoms and slowing tumor growth in patients with hormone secreting pituitary adenomas and carcinomas. The targe...
Read more

Enhancing Patient Care and Comfort: The Evolution of Hospital Beds

Image
  Hospital beds play a crucial role in patient care, providing comfort, safety, and functionality for individuals requiring medical attention. Over the years, advancements in technology and design have revolutionized hospital beds, leading to improved patient outcomes and caregiver efficiency. From basic adjustable beds to sophisticated models equipped with cutting-edge features, the evolution of hospital beds has transformed the healthcare landscape. Evolution of Hospital Beds: Historically, hospital beds were simple in design, primarily consisting of a metal frame with adjustable height and manual controls. However, as medical practices advanced and patient needs became more complex, the demand for more versatile and ergonomic hospital beds grew. In recent decades, significant strides have been made in the development of hospital bed technology. Modern hospital beds are designed with a focus on patient comfort, safety, and mobility. Features such as electronic controls, motorize...
Read more

Dry Eye Disease Market is Estimated to Witness High Growth Owing to Rising Awareness About Disease Management

Image
  Dry eye disease, also known as keratoconjunctivitis sicca, is a multifactorial disease of the ocular surface characterized by lack of sufficient moisture and tear film instability. Common symptoms of dry eye include stingy or burning sensation in eyes and blurred vision.   Market Dynamics : The Dry Eye Disease Market is witnessing high growth owing to rising awareness about disease management and increasing number of people experiencing symptoms of dry eyes. According to the report, increasing usage of electronic devices and prolonged screen time is a major driver fueling the demand for dry eye treatments. Additionally, growing geriatric population worldwide who are more prone to dry eyes is also contributing to the market growth. Availability of various treatment options along with new product launches is further expected to boost the market during forecast period.   Increasing Prevalence of Dry Eye Disease is Driving Market Growth   One of the major market drive...
Read more